Learn More
PURPOSE Acute myelogenous leukemia (AML) is a disease originating from normal hematopoietic CD34+ CD38- progenitor cells. Modulation of the multidrug ATP-binding cassette transporter ABCB1 has not(More)
Purpose: Acute myelogenous leukemia (AML) is a disease originating from normal hematopoietic CD34CD38 progenitor cells. Modulation of the multidrug ATP-binding cassette transporter ABCB1 has not(More)